Nuclear Medicine in Breast Cancer Based on FOCUS Meeting 6
Breast cancer is the most relevant cancer in women worldwide. It is the second most frequently diagnosed cancer (after lung cancer) and the first leading cause of cancer-related death in […]
12 events found.
Events
-
-
Future Health Lab Alfred-Adler-Straße 1, Vienna, Austria
-
To AI or not to AI in Neurology: That is the Question
This webinar will explore state-of-the-art AI approaches for advancing neuroimaging, with a particular focus on quantitative PET. It will cover the entire imaging pipeline, from preprocessing, acquisition, and tomographic reconstruction to […]
Free -
-
Personalized Medicine in Prostate Cancer: From Diagnostic to Therapy
This course has been accredited with 3 CME credits by the UEMS EACCME. Radiolabelled prostate-specific membrane antigen (PSMA) is increasingly used in imaging and treatment of prostate cancer. PSMA-directed radionuclide therapy […]
Free -
-
Innovations in Theranostics for Neuroblastoma
This course provides a comprehensive update on instrumental and radiopharmaceutical innovations in the diagnosis and treatment of neuroblastoma. Participants will explore current and emerging imaging modalities, with a comparative analysis […]
-
Beyond Single Modality: The Future of Cancer Staging with Hybrid Scanners
This webinar will be on the future of cancer staging with hybrid imaging technologies. Participants will gain an overview of advanced PET/CT, SPECT/CT, and PET/MRI systems, learning how hybrid imaging […]
-
EANM Focus Meeting 7: Molecular Imaging for a Personalised Treatment in Alzheimer’s Disease
Alzheimer’s disease is a growing global health concern, now facing a pivotal moment with the approval of disease-specific treatments. This Focus Meeting brought together international experts under the theme ‘An accurate […]
Free -
-
Radiobiological Aspects of PRRT
This webinar will examine the fundamental differences between targeted radionuclide therapy (TRT) and conventional external beam radiotherapy (EBRT), integrating physical, dosimetric, and radiobiological perspectives relevant to clinical practice. Drawing on […]
-
Dose-Effect Response to Targeted Radionuclide Therapy
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaThis intensive 1,5-day course bridges the gap between radiobiology, dosimetry, and clinical practice in targeted radionuclide therapy. Designed for early-career nuclear medicine physicians and medical physicists, the programme explores dose-response […]
€950 -
FDG PET/CT in Inflammation and Infection: from Theory to Clinical Practice!
Imaging of infection and inflammation has been part of nuclear medicine since the 1970s. Over the past two decades, the growing role of FDG PET/CT in diagnosing and monitoring the […]
-
-
Open your Heart on SPECT and PET Studies: Synergistic Information from the CT
This webinar will cover synergetic information derived from the CT component in SPECT/CT and PET/CT examinations: the first part we will focus on cardiac calcifications, offering valuable insights into their […]
-
Nuclear Medicine in FUO/IUO: Why Are Children Different?
Future Health Lab Alfred-Adler-Straße 1, Vienna, AustriaThis 1,5-day course focuses on the growing field of integrated imaging in infectious and inflammatory diseases in children, with an emphasis on hybrid imaging. The panelists will introduce the participants […]
-
-
Dosimetry in Clinical Trials
Targeted Radionuclide Therapy (TRT) is an expanding field of cancer treatment in which radiopharmaceuticals—comprising a radionuclide linked to a tumour-targeting biological vector—are administered to deliver cytotoxic radiation doses selectively to […]